GET THE PREMIUM SUBSCRIPTION FREE FOR 14 DAYS!

Alnylam Pharmaceuticals Stock Price (Quote) NASDAQ:ALNY

$172.95 ( 0.99% ) Tuesday, 22nd Jun 2021

Range Low Price High Price Comment
30 days $136.85 $177.53 Tuesday, 22nd Jun 2021 ALNY stock ended at $172.95. This is 0.99% more than the trading day before Monday, 21st Jun 2021. During the day the stock fluctuated 2.74% from a day low at $168.51 to a day high of $173.13.
90 days $125.08 $177.53
52 weeks $119.29 $178.41

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
2021-06-22 $171.40 $173.13 $168.51 $172.95 721 099
2021-06-21 $175.86 $175.86 $169.70 $171.26 1 059 469
2021-06-18 $171.08 $177.53 $169.97 $176.89 1 522 001
2021-06-17 $167.92 $172.53 $167.92 $172.25 627 129
2021-06-16 $166.45 $168.37 $164.94 $168.30 707 264
2021-06-15 $166.50 $168.78 $165.49 $166.50 981 515
2021-06-14 $165.42 $167.37 $164.05 $166.66 820 657
2021-06-11 $161.76 $165.33 $161.76 $165.02 709 382
2021-06-10 $158.01 $163.29 $156.85 $163.26 647 900
2021-06-09 $152.25 $157.50 $151.31 $157.41 648 814
2021-06-08 $152.00 $153.25 $149.98 $151.08 470 538
2021-06-07 $145.88 $150.85 $144.45 $150.46 844 937
2021-06-04 $147.43 $148.00 $144.02 $145.60 413 260
2021-06-03 $141.82 $148.59 $140.39 $147.29 556 274
2021-06-02 $143.86 $145.24 $142.16 $142.85 760 943
2021-06-01 $142.23 $145.15 $141.11 $144.28 583 534
2021-05-28 $140.95 $144.72 $139.85 $141.99 490 460
2021-05-27 $139.59 $142.25 $136.85 $140.23 409 929
2021-05-26 $140.74 $141.54 $138.28 $138.80 427 855
2021-05-25 $139.35 $140.39 $138.05 $139.40 504 254
2021-05-24 $141.34 $141.56 $138.14 $138.28 339 034
2021-05-21 $140.63 $142.05 $138.98 $140.06 328 349
2021-05-20 $135.25 $140.68 $132.46 $140.10 367 493
2021-05-19 $133.24 $137.24 $133.02 $134.93 432 355
2021-05-18 $135.39 $138.44 $134.23 $135.15 238 221
2021-05-17 $135.21 $136.69 $134.06 $135.89 262 111
2021-05-14 $133.68 $137.65 $131.58 $135.70 449 507
2021-05-13 $134.29 $134.92 $127.72 $132.92 606 871
2021-05-12 $131.27 $135.24 $131.07 $133.36 440 709
2021-05-11 $126.45 $133.36 $125.08 $132.41 496 783
2021-05-10 $131.28 $131.28 $127.22 $128.63 307 238
2021-05-07 $133.44 $135.49 $130.76 $131.30 238 536
2021-05-06 $132.00 $134.00 $128.71 $132.10 630 167
2021-05-05 $131.64 $133.29 $129.14 $132.67 612 599
2021-05-04 $134.64 $135.69 $130.46 $131.57 570 957
2021-05-03 $140.48 $140.61 $134.23 $135.34 551 974
2021-04-30 $139.11 $144.45 $139.11 $140.64 430 042
2021-04-29 $145.00 $147.98 $137.52 $139.69 731 446
2021-04-28 $140.99 $144.99 $139.07 $143.53 454 047
2021-04-27 $142.14 $144.06 $140.75 $141.30 541 942
2021-04-26 $137.78 $143.35 $135.97 $142.90 683 224
2021-04-23 $138.59 $140.47 $135.62 $136.72 327 950
2021-04-22 $136.45 $140.41 $134.67 $137.77 324 371
2021-04-21 $136.94 $138.48 $134.12 $137.53 236 264
2021-04-20 $131.75 $136.91 $131.75 $136.03 506 635
2021-04-19 $138.34 $140.82 $136.09 $137.40 492 633
2021-04-16 $139.59 $140.06 $137.39 $138.88 766 862
2021-04-15 $139.76 $142.71 $138.73 $139.02 428 329
2021-04-14 $137.40 $140.37 $136.18 $138.31 566 029
2021-04-13 $136.01 $137.00 $133.12 $136.23 477 023

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapeutics based on RNA interference. The company’s clinical development programs include Patisiran and Revusiran, which are in Phase III clinical trials for the treatment of transthyretin amyloidosis (ATTR); ALN-TTRsc02, an investigational RNAi therapeutic targeting TTR for the treatment of various forms of ATTR amyloidosis; Fitusiran, an... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT